Oncology Medical News about IMP3

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes
Modern Pathology, 09/17/09

Mentrikoski MJ et al. – IMP3 is helpful in distinguishing benign intranodal nevi from metastatic melanoma in sentinel lymph node biopsy specimens, and could be a valuable diagnostic adjunct in sentinel lymph node biopsy assessment in which questions arise as to the malignancy of the melanocytes present.

<< Previous
Irreversible pan-ErbB tyrosine kinase inhibitors and breast...

Next >>
The alternative lengthening of telomeres phenotype in breast...

Analysis of IMP3 Expression in Normal and Neoplastic Human Pituitary Tissues
Endocrine Pathology, 11/10/09 Relevance Score: 87%